ICOSAGEN AS
Date of report 14.07.2026
ICOSAGEN AS
Registered| start | end |
|---|---|
| 01.12.1999 | - |
Former names
- osaühing Quattromed
- aktsiaselts Quattromed
keywords
- riik ja ühiskond
- teadusasutused
- teadustegevus tehnoloogias
ICOSAGEN AS
Scores and ratings
Reputation score
Credit Score
Open the reports you want to print
Employees and salaries
ICOSAGEN AS
Employee taxes and performance analysis| Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
|---|---|---|---|---|
| 2026 II | ...... | ...... | ...... | ...... |
| 2026 I | ...... | ...... | ...... | ...... |
| 2025 IV | ...... | ...... | ...... | ...... |
| 2025 III | ...... | ...... | ...... | ...... |
| 2025 II | ...... | ...... | ...... | ...... |
| 2025 I | ...... | ...... | ...... | ...... |
| 2024 IV | ...... | ...... | ...... | ...... |
| 2024 III | ...... | ...... | ...... | ...... |
| 2024 II | ...... | ...... | ...... | ...... |
| 2024 I | ...... | ...... | ...... | ...... |
| 2023 IV | ...... | ...... | ...... | ...... |
| 2023 III | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... |
| 2023 I | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... |
| 2022 III | ...... | ...... | ...... | ...... |
| 2022 II | ...... | ...... | ...... | ...... |
| 2022 I | ...... | ...... | ...... | ...... |
| 2021 IV | ...... | ...... | ...... | ...... |
| 2021 III | ...... | ...... | ...... | ...... |
| 2021 II | ...... | ...... | ...... | ...... |
| 2021 I | ...... | ...... | ...... | ...... |
| 2020 IV | ...... | ...... | ...... | ...... |
| 2020 III | ...... | ...... | ...... | ...... |
| 2020 II | ...... | ...... | ...... | ...... |
| 2020 I | ...... | ...... | ...... | ...... |
| 2019 IV | ...... | ...... | ...... | ...... |
| 2019 III | ...... | ...... | ...... | ...... |
| 2019 II | ...... | ...... | ...... | ...... |
| 2019 I | ...... | ...... | ...... | ...... |
| 2018 IV | ...... | ...... | ...... | ...... |
| 2018 III | ...... | ...... | ...... | ...... |
| 2018 II | ...... | ...... | ...... | ...... |
| 2018 I | ...... | ...... | ...... | ...... |
| 2017 IV | ...... | ...... | ...... | ...... |
| 2017 III | ...... | ...... | ...... | ...... |
| 2017 II | ...... | ...... | ...... | ...... |
| 2017 I | ...... | ...... | ...... | ...... |
| 2016 IV | ...... | ...... | ...... | ...... |
| 2016 III | ...... | ...... | ...... | ...... |
| 2016 II | ...... | ...... | ...... | ...... |
| 2016 I | ...... | ...... | ...... | ...... |
| 2015 IV | ...... | ...... | ...... | ...... |
| 2015 III | ...... | ...... | ...... | ...... |
| 2015 II | ...... | ...... | ...... | ...... |
| 2015 I | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
ICOSAGEN AS
Decision-makersFormer decision-makers
......
Credit Score: ...
Reputation score: ...
Date of birth: ......
Active relations 4
......
Credit Score: ...
Reputation score: ...
Date of birth: ......
Active relations 3
ICOSAGEN AS
Former decision-makers......
Credit Score: ...
Reputation score: ...
Date of birth: ......
Active relations 4
......
Credit Score: ...
Reputation score: ...
Date of birth: ......
Active relations 0
......
Credit Score: ...
Reputation score: ...
Date of birth: ......
Active relations 0
......
Credit Score: ...
Reputation score: ...
Date of birth: ......
Active relations 0
......
Credit Score: ...
Reputation score: ...
Date of birth: ......
Active relations 8
......
Credit Score: ...
Reputation score: ...
Date of birth: ......
Active relations 0
ICOSAGEN AS
History of right of representationICOSAGEN AS
OwnersFormer owners
| Name | Credit Score | Payment | Beginning | Type | Holding |
|---|---|---|---|---|---|
| ...... | ...... | ...... |
100%
|
Former owners
| Name | Credit Score | Payment | Beginning | Ending |
|---|---|---|---|---|
| ...... | ...... | ...... | ||
more_horiz
| ...... | ...... | ...... | |
| ...... | ...... | ...... | ||
more_horiz
| ...... | ...... | ...... | |
| ...... | ...... | ...... | ||
more_horiz
| ...... | ...... | ...... | |
more_horiz
| ...... | ...... | ...... | |
| ...... | ...... | ...... | ||
more_horiz
| ...... | ...... | ...... | |
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
more_horiz
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... | |
more_horiz
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... | |
| ...... | ...... | ...... | ||
check_indeterminate_small
| ...... | ...... | ...... | |
| ...... | ...... | ...... | ||
check_indeterminate_small
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... | |
more_horiz
| ...... | ...... | ...... | |
more_horiz
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... | |
more_horiz
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... |
ICOSAGEN AS
Other related partiesFormer other persons
Other related parties (invalid relations)
| Name | Credit Score | Part | Beginning | Ending |
|---|---|---|---|---|
check_indeterminate_small
| ...... | ...... | ...... | |
| ...... | ...... | ...... | ||
check_indeterminate_small
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... | |
more_horiz
| ...... | ...... | ...... | |
more_horiz
| ...... | ...... | ...... | |
more_horiz
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... | |
more_horiz
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... | |
check_indeterminate_small
| ...... | ...... | ...... |
ICOSAGEN AS
Subsidiaries and associatesFormer subsidiaries and associates
Former subsidiaries and associates
| Name | Credit Score | Payment | Beginning | Ending |
|---|---|---|---|---|
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... |
Beneficiaries
Volumes and values of beneficiaries' assets
Finances and assets
ICOSAGEN AS
GoodwillICOSAGEN AS
Taxes paid and estimated average salariesICOSAGEN AS
Quarterly indicators| Quarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
|---|---|---|---|---|---|---|---|
| 2026 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2026 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2025 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2025 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2025 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2025 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
ICOSAGEN AS
Sales revenue by business areaICOSAGEN AS
Sales revenue by countryICOSAGEN AS
Financial indicators and prognosisICOSAGEN AS
Financial raiting: "GOOD" (2026 prognosis)ICOSAGEN AS
Annual reports| Year | Period | Submitted | Report PDF |
|---|---|---|---|
| 2025 | 01.01.2025–31.12.2025 | 29.06.2026 | ...... |
| 2024 | 01.01.2024–31.12.2024 | 30.06.2025 | ...... |
| 2023 | 01.01.2023–31.12.2023 | 11.06.2024 | ...... |
| 2022 | 01.01.2022–31.12.2022 | 19.06.2023 | ...... |
| 2021 | 01.01.2021–31.12.2021 | 30.06.2022 | ...... |
| 2020 | 01.01.2020–31.12.2020 | 29.10.2021 | ...... |
| 2019 | 01.01.2019–31.12.2019 | 30.06.2020 | ...... |
| 2018 | 01.01.2018–31.12.2018 | 25.06.2019 | ...... |
| 2017 | 01.01.2017–31.12.2017 | 08.06.2018 | ...... |
| 2016 | 01.01.2016–31.12.2016 | 29.06.2017 | ...... |
| 2015 | 01.01.2015–31.12.2015 | 30.06.2016 | ...... |
| 2014 | 01.01.2014–31.12.2014 | 30.06.2015 | ...... |
| 2013 | 01.01.2013–31.12.2013 | 30.06.2014 | ...... |
| 2012 | 01.01.2012–31.12.2012 | 26.06.2013 | ...... |
| 2011 | 01.01.2011–31.12.2011 | 15.06.2012 | ...... |
| 2010 | 01.01.2010–31.12.2010 | 11.05.2011 | ...... |
| 2009 | 01.01.2009–31.12.2009 | 16.06.2010 | ...... |
| 2008 | 01.01.2008–31.12.2008 | 18.06.2009 | ...... |
| 2007 | 01.01.2007–31.12.2007 | 06.05.2008 | ...... |
| 2006 | 01.01.2006–31.12.2006 | 09.05.2007 | ...... |
| 2005 | 01.01.2005–31.12.2005 | 21.09.2006 | ...... |
| 2004 | 01.01.2004–31.12.2004 | 19.05.2005 | ...... |
| 2003 | 01.01.2003–31.12.2003 | 30.06.2004 | ...... |
| 2002 | 01.01.2002–31.12.2002 | 15.05.2003 | ...... |
| 2001 | 01.01.2001–31.12.2001 | 14.06.2002 | ...... |
| 2000 | 01.01.2000–31.12.2000 | 21.06.2001 | ...... |
Liabilities and debts
ICOSAGEN AS
Credit score history and prognosis... €
......
Business risk classes:
Trustworthy NeutralICOSAGEN AS
Reports and assets-liabilities overview 14.07.2026ICOSAGEN AS
Claims historyTotal debt claims: ...... €
| ...... | ...... |
ICOSAGEN AS
Income (turnover) and expenditure (taxes paid)| Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
|---|---|---|---|---|---|
| 2026 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2026 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2025 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2025 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2025 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2025 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 I | * ...... € | ...... € | ...... € | ...... € | ...... |
ICOSAGEN AS
Bailiff's enforcement proceedings as of 14.07.2026Bailiff's enforcement proceedings MISSING
ICOSAGEN AS
Regulations of the Payment Order Department as of 14.07.2026Regulations of the Payment Order Department MISSING
ICOSAGEN AS
Court orders in the register as of 14.07.2026Puuduste kõrvaldamise määrus kandeväliste andmete parandamiseks
Regulation number: Ä 20015696 / M17
Regulation status has entered into force: 03.07.2024
Date of enforcement of order or additional period: 02.07.2024
Regulation status: Puudused kõrvaldatud
Puuduste kõrvaldamise määrus
Regulation number: Ä 20015696 / M16
Regulation status has entered into force: 26.08.2020
Date of enforcement of order or additional period: 26.08.2020
Regulation status: Jõustunud
Puuduste kõrvaldamise määrus kandeväliste andmete parandamiseks
Regulation number: Ä 20015696 / M15
Regulation status has entered into force: 29.07.2020
Date of enforcement of order or additional period: 23.07.2020
Regulation status: Puudused kõrvaldatud
ICOSAGEN AS
Decisions of the Consumer Disputes Committee as of 14.07.2026Consumer disputes MISSING
ICOSAGEN AS
Court hearings as of 14.07.2026Court hearings MISSING
ICOSAGEN AS
Rulings as of 14.07.2026Kohtumäärus tsiviilasjas nr 2-23-8487/41
Tartu Maakohus Võru kohtumaja Võrus
| Related companies: | |
| Number of the case: | 2-23-8487/41 |
| Type of procedure: | Tsiviilasi |
| Court: | Tartu Maakohus Võru kohtumaja Võrus |
| Type of solution: | Kohtumäärus |
| Solution subcategory: | - |
| Composition of the Court: | Mari Schihalejev |
| Commencement of the Court case: | 09.06.2023 |
| Type of procedure: | Kohtu I astme menetlus |
| Commencement of proceedings: | 09.06.2023 |
| Court case category: | Saneerimine |
| Keyword: | - |
| Court decision date: | 11.09.2023 |
| Entry into force: | 05.10.2023 |
| Dissenting opinion: | |
| ECLI identifier: ? |
ECLI:EE:TMK:2023:2.23.8487.16436 |
ICOSAGEN AS
Notices and announcements as of 14.07.2026Notice of granting or refusing to grant an environmental permit
Avaldamise lõpp: 12.12.2122
Keskkonnaamet teatab, et Icosagen AS (registrikood: 10565884) (aadress Eerika tee 1, Õssu küla, Kambja vald, Tartu maakond, 61713) 15.09.2022 esitatud keskkonnaloa taotluse nr T-KL/1009254-3 alusel väljastas keskkonnaloa nr KL-517100 aadressil Eerika tee 1, Õssu küla, Kambja vald, Tartu maakond (katastritunnus 28301:001:1074) jäätmete taaskasutamiseks (autoklaavitakse tervishoiu vedelaid ja tahkeid riskijäätmeid (ohutuks muutmine; taaskasutamistoimingu kood R12p)
Haldusakti ja muude asjasse puutuvate dokumentidega on võimalik tutvuda Keskkonnaameti kontorites üle Eesti
Digitaalselt on dokumendid kättesaadavad Keskkonnaameti keskkonnaotsuste infosüsteemis https://kotkas.envir.ee/menetlus/M-120788.
Roheline 64, Pärnu
Telefon: 662 5999
E-post: INFO@KESKKONNAAMET.EE
Notice of publication of a draft environmental permit
Avaldamise lõpp: 10.11.2122
Keskkonnaamet teatab, et Icosagen AS (registrikood: 10565884) (aadress Eerika tee 1, Õssu küla, Kambja vald, Tartu maakond, 61713) 15.09.2022 esitatud keskkonnaloa taotluse nr T-KL/1009254-3 alusel on Keskkonnaamet ette valmistanud keskkonnaloa nr KL-517100 andmise otsuse ja sellega seonduva keskkonnamõju hindamise algatamata jätmise otsuse eelnõud.
Ettevõte taotleb keskkonnaluba jäätmete käitlemiseks ja tema käitluskoht asub aadressil Eerika tee 1, Õssu küla, Kambja vald, Tartu maakond (katastritunnus 28301:001:1074). Icosagen AS soovib autoklaavida (muuta ohutuks; taaskasutamistoimingu kood R12p) tervishoiu vedelaid ja tahkeid riskijäätmeid ning anda edasi jäätmekäitlejale põletamiseks (R1).
Eelnõu(de) ja muude asjassepuutuvate dokumentidega on võimalik tutvuda Keskkonnaameti kontorites üle Eesti.
Eelnõud on digitaalselt kättesaadavad keskkonnaotsuste infosüsteemis https://kotkas.envir.ee/menetlus/M-120788
Ettepanekuid ja vastuväiteid eelnõu(de)le saab esitada Keskkonnaametile suuliselt või kirjalikult e-posti aadressil info@keskonnaamet.ee alates teate ilmumisest ametlikus väljaandes Ametlikud Teadaanded.
Roheline 64, Pärnu
Telefon: 662 5999
E-post: INFO@KESKKONNAAMET.EE
Notice of initiation of proceedings for an environmental permit
Avaldamise lõpp: 15.10.2122
Keskkonnaamet teatab, et Icosagen AS (registrikood: 10565884) (aadress Eerika tee 1, Õssu küla, Kambja vald, Tartu maakond, 61713) esitas 15.09.2022 keskkonnaloa taotluse nr T-KL/1009254-3. Ettevõte taotleb keskkonnaluba jäätmete käitlemiseks ja tema käitluskoht asub aadressil Eerika tee 1, Õssu küla, Kambja vald, Tartu maakond (katastritunnus 28301:001:1074). Icosagen AS soovib autoklaavida tervishoiu vedelaid ja tahkeid riskijäätmeid autoklaavida (muuta ohutuks; taaskasutamistoimingu kood R12p) ning anda edasi jäätmekäitlejale põletamiseks (R1).
Keskkonnaloa taotlusega ja muude asjassepuutuvate dokumentidega on võimalik tutvuda Keskkonnaameti kontorites üle Eesti.
Taotlus on digitaalselt kättesaadav keskkonnaotsuste infosüsteemis https://kotkas.envir.ee/permits/public_document_view?document_id=88510
Kuni keskkonnaloa andmise või andmisest keeldumise otsuse tegemiseni on igaühel õigus esitada Keskkonnaametile põhjendatud ettepanekuid ja vastuväiteid. Ettepanekuid ja vastuväiteid võib esitada suuliselt või kirjalikult e-posti aadressile info@keskkonnaamet.ee või postiaadressile Roheline 64, 80010 Pärnu.
Keskkonnaloa andmise või andmisest keeldumise otsuse eelnõu valmimisest teavitab Keskkonnaamet täiendavalt ametlikus väljaandes Ametlikud Teadaanded.
Roheline 64, Pärnu
Telefon: 662 5999
E-post: INFO@KESKKONNAAMET.EE
Marketing
Business network
ICOSAGEN AS
Business networkSign in
To expand your connections, log in to the "Networks" environment
Beneficiaries network
ICOSAGEN AS
Networks - BeneficiariesSign in
To expand your connections, log in to the "Networks" environment
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events found.
Failed to load monitoring events.